✓ No loaded language, vague sourcing, or framing detected.
The FDA has authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System, the first device to continuously monitor both ketone and blood sugar levels for individuals aged 2 and older with diabetes. The device provides real-time data and alerts to help prevent diabetic ketoacidosis, a serious complication of diabetes.
Our neutral summary
The FDA has authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System, the first device to continuously monitor both ketone and blood sugar levels for individuals aged 2 and older with diabetes. The device provides real-time data and alerts to help prevent diabetic ketoacidosis, a serious complication of diabetes.
The reporting belongs to Hacker News — Front Page; we don't reproduce it.
No note attached
on this article.
FDA authorizes first wearable device that monitors ketone and blood sugar levels
FDA authorizes wearable device for monitoring ketone and blood sugar levels